Medicare Enrolled
Dr. Muhammad Awan, MD
Optician · Orlando, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Awan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Awan?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Awan
Dr. Muhammad Awan is an optician specialist in Orlando, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Awan performed 1,009 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Awan received a total of $6,266 from 54 pharmaceutical and/or device companies across 396 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Awan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ 1,009 Medicare services
$6,266 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 68874 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗1,009
Medicare services
Bottom 42% in FL for optician
Not available
Unique patients (not deduplicated)
$49
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
269 | $89 | $190 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
137 | $8 | $10 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
93 | $128 | $235 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
88 | $0 | $10 |
| Annual alcohol misuse screening, 5 to 15 minutes | 80 | $18 | $40 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
75 | $15 | $40 |
| Annual depression screening | 61 | $18 | $35 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
56 | $9 | $44 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
55 | $64 | $140 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
26 | $30 | $57 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
24 | $4 | $20 |
| Quadrivalent influenza vaccine, preservative-free A flu shot containing four strains of the influenza virus, formulated without preservatives, administered in a 0.5 ml dose. |
23 | $22 | $50 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
22 | $152 | $370 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$6,266
Total received (2018-2024)
Avg $895/year across 7 years
Top 20% in FL for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
54
Companies
396
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$619
2023
$613
2022
$1,013
2021
$1,178
2020
$455
2019
$878
2018
$1,511
Payments by company (2024)
Novo Nordisk Inc
$133
IBSA Pharma Inc.
$108
Lilly USA, LLC
$78
Boehringer Ingelheim Pharmaceuticals, Inc.
$69
Astellas Pharma US Inc
$42
Insulet Corporation
$40
ABBVIE INC.
$26
PFIZER INC.
$21
GlaxoSmithKline, LLC.
$19
Almatica Pharma LLC
$18
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$17
Phathom Pharmaceuticals, Inc.
$17
AstraZeneca Pharmaceuticals LP
$17
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$15
Top 3 companies account for 51.5% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$1,051
AstraZeneca Pharmaceuticals LP
$489
Novartis Pharmaceuticals Corporation
$415
Boehringer Ingelheim Pharmaceuticals, Inc.
$408
IBSA Pharma Inc.
$401
GlaxoSmithKline, LLC.
$395
Astellas Pharma US Inc
$358
Lilly USA, LLC
$326
AbbVie Inc.
$215
Janssen Pharmaceuticals, Inc
$206
SANOFI-AVENTIS U.S. LLC
$181
Amgen Inc.
$175
ABBVIE INC.
$169
PFIZER INC.
$154
Esperion Therapeutics, Inc.
$148
Xeris Pharmaceuticals, Inc.
$123
Merck Sharp & Dohme Corporation
$108
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$103
Amarin Pharma Inc.
$77
Eisai Inc.
$64
Biohaven Pharmaceutical Holding Company Ltd.
$48
Insulet Corporation
$40
Bayer Healthcare Pharmaceuticals Inc.
$38
Teva Pharmaceuticals USA, Inc.
$32
MannKind Corporation
$28
Radius Health, Inc.
$28
Nabriva Therapeutics, plc
$25
Avanir Pharmaceuticals, Inc.
$23
Shire North American Group Inc
$23
Mylan Specialty L.P.
$23
Medtronic, Inc.
$23
Bayer HealthCare Pharmaceuticals Inc.
$21
Antares Pharma, Inc.
$20
Allergan Inc.
$19
Medtronic MiniMed, Inc.
$19
Biohaven Pharmaceuticals, Inc.
$18
Allergan, Inc.
$18
Almatica Pharma LLC
$18
Horizon Therapeutics plc
$18
Shield Therapeutics Inc
$18
SANOFI PASTEUR INC.
$18
Phathom Pharmaceuticals, Inc.
$17
Sunovion Pharmaceuticals Inc.
$17
Merck Sharp & Dohme LLC
$16
Renalytix AI, Inc.
$15
Grifols USA, LLC
$15
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$15
Currax Pharmaceuticals LLC
$14
Takeda Pharmaceuticals U.S.A., Inc.
$13
Gilead Sciences, Inc.
$13
Dexcom, Inc.
$13
Valeritas, Inc.
$12
ARBOR PHARMACEUTICALS, INC.
$12
VistaPharm, Inc.
$11
Top 3 companies account for 31.2% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · AFREZZA · AIRSUPRA · AJOVY · ANORO · ANORO ELLIPTA · Aimovig · BELSOMRA · BEVESPI AEROSPHERE · BREO · BREZTRI · BYSTOLIC · CAPLYTA · CHANTIX · COLOGUARD DNA CAPTURE REAGENTS · CONTRAVE · CREON · Dayvigo · Descovy · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · Edarbyclor · FARXIGA · FASENRA · FLUZONE HIGH-DOSE · GVOKE HYPOPEN · GVOKE PFS · Guardian Connect · INVOKANA · InPen · JANUVIA · JARDIANCE · KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT · Kerendia · LEQVIO · LICART · LINZESS · LONHALA MAGNAIR · LOREEV XR · Licart · MOUNJARO · MOVANTIK · MYDAYIS · MYRBETRIQ · NEXLETOL · NUEDEXTA · NURTEC ODT · Omnipod · Otezla · Ozempic · PENNSAID · PREMARIN · Prolastin-C · Prolia · QULIPTA · RELISTOR · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SPIRIVA · SPIRIVA RESPIMAT · STEGLATRO · STIOLTO · STIOLTO RESPIMAT · SYMBICORT · SYNTHROID · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · Thyquidity · Tirosint · Tresiba · Tymlos · UBRELVY · V-GO · VESICARE · VOQUEZNA · VRAYLAR · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN · XIFAXANIBSD · XYOSTED · Xenleta · Xultophy 100/3.6 · Yupelri · ZEPBOUND
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Opticians in nearby ZIP areas
318
County median income
$77,011
Nearest hospital to ZIP centroid (approximate)
ORLANDO HEALTH
4.5 mi
4.5 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Awan is a clinical cardiology specialist, with moderate Medicare volume, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Awan experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Awan performed 269 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Awan receive payments from pharmaceutical companies?
Yes. Dr. Awan received a total of $6,266 from 54 companies across 396 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Awan's costs compare to other opticians in Orlando?
Dr. Awan's average Medicare payment per service is $49. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Awan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Orlando
Browse opticians in Orlando ranked by procedure volume and transparency data.
Highest volume
Top Opticians in FL
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in FL
Which FL opticians receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology